Stocklytics Platform
Asset logo for symbol QGEN
QIAGEN NV
QGEN51
$45.90arrow_drop_up0.02%$0.01
Asset logo for symbol QGEN
QGEN51

$45.90

arrow_drop_up0.02%

Income Statement (QGEN)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
EBIT$122.80M$98.24M$134.49M$122.86M$124.41M
EBITDA$176.20M$152.57M$186.06M$173.43M$175.55M
gross Profit$315.21M$288.26M$345.14M$297.96M$312.15M
NET Income-$183.46M$80.67M$97.66M$77.81M$80.78M
total Revenue$496.34M$458.79M$509.16M$475.89M$494.85M

Balance Sheet (QGEN)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
cash Equivalents-----
net Debt$867.97M$989.66M$943.04M$903.03M$1.27B
stockholders Equity$3.40B$3.59B$3.80B$3.69B$3.62B
total Assets$5.58B$5.80B$6.11B$5.90B$6.34B
total Debt$1.40B$1.50B$1.61B$1.48B$1.88B
total Liabilities$2.17B$2.20B$2.30B$2.21B$2.72B

Cash Flow (QGEN)

itemJun 2024Mar 2024Dec 2023Sep 2023Jun 2023
financing Cash Flow-$127.38M-$292.08M-$7.43M-$401.09M-$15.47M
free Cash Flow$127.70M$94.71M$99.14M$83.64M$80.34M
investing Cash Flow---$248.36M$156.27M
operating Cash Flow$166.61M$133.07M$151.36M$124.68M$111.47M

QIAGEN NV (QGEN) Financials

The income statement for QIAGEN NV (QGEN) provides a detailed overview of the company's financial performance. It shows the company's revenue, expenses, and net income for a specific period. The ebit, or earnings before interest and taxes, is a measure of the company's profitability. It is calculated by subtracting the company's operating expenses from its gross profit. The ebitda, or earnings before interest, taxes, depreciation, and amortization, is another measure of profitability. It provides a clearer picture of the company's operating performance by excluding non-cash expenses and one-time items. The gross profit represents the difference between the company's revenue and its cost of goods sold. It is a key indicator of the company's ability to generate profit from its core operations. The net income from stockholders is the amount of profit left after all expenses, including taxes and interest, have been paid. It represents the return on investment for the company's shareholders. The total revenue is the sum of all the company's sources of income, including sales of products and services. It provides an overall picture of the company's financial performance. The balance sheet for QIAGEN NV (QGEN) provides a snapshot of the company's financial position at a specific point in time. It shows the company's assets, liabilities, and stockholders' equity. The cash equivalents represent the company's short-term investments that can be quickly converted into cash. They provide liquidity and flexibility to the company. The net debt is the difference between the company's total debt and its cash equivalents. It represents the company's overall debt load. The stockholders' equity is the residual interest in the assets of the company after deducting its liabilities. It represents the company's net worth. The total assets are the sum of all the company's resources, including cash, inventory, property, and investments. They represent the company's economic value. The total debt is the sum of all the company's outstanding debts, including loans and bonds. It represents the company's financial obligations. The total liabilities are the sum of all the company's debts and obligations. They represent the company's claims against its assets. The cash flow statement for QIAGEN NV (QGEN) provides information about the company's cash inflows and outflows. It shows how the company generates and uses cash. The financing cash flow represents the cash flows related to the company's financing activities, such as borrowing or repaying loans, issuing or repurchasing stock, and paying dividends. The free cash flow is the amount of cash generated by the company's operations after deducting its capital expenditures. It represents the cash available for the company to invest in new projects, pay dividends, or reduce debt. The investing cash flow represents the cash flows related to the company's investing activities, such as buying or selling assets and making investments. The operating cash flow represents the cash flows related to the company's core operations, such as sales and expenses.
QIAGEN NV (QGEN) is a leading provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company's instrument financials play a crucial role in evaluating its financial performance and health. The income statement provides a snapshot of the company's revenue, expenses, and profitability. It includes key metrics such as ebit (earnings before interest and taxes) and ebitda (earnings before interest, taxes, depreciation, and amortization), which help assess the company's operating performance. The gross profit indicates the profitability of its core operations, while the net income from stockholders reflects the return on investment for shareholders. The total revenue reflects the overall financial performance and growth of the company. The balance sheet reveals the company's assets, liabilities, and stockholders' equity. The cash equivalents are highly liquid assets that can be easily converted into cash, providing flexibility and liquidity. The net debt represents the company's overall debt burden. Stockholders' equity represents the ownership interest in the company. Total assets represent the value of the company's resources, while total debt and liabilities signify financial obligations. The cash flow statement depicts the inflows and outflows of cash, revealing how the company generates and utilizes cash. The financing cash flow reflects the cash flows related to the company's financing activities, such as issuing or repurchasing stock or paying dividends. The free cash flow indicates the cash available for investments or debt reduction after accounting for operating and capital expenditures. The investing cash flow shows the cash flows related to acquisitions or divestitures. The operating cash flow reflects the cash generated or used in the company's core operations, serving as a critical indicator of its financial viability.
add QIAGEN NV to watchlist

Keep an eye on QIAGEN NV

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media